Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3,975.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 4,500.00
  • 52 Week Low: 3,825.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 2,009
  • Market Cap: £207.07m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 518,176 £20,597,496
Ian James Nicholson 15,500 £616,125

Major Shareholders

Notifier** Holding Value*
Castlefield Fund Partners Limited 985,000 £39,153,750
Liontrust Investment Partners LLP 522,952 £20,787,342
Miton Group plc 508,135 £20,198,366
The Diverse Income Trust plc 302,300 £12,016,425
Wasatch Advisors, Inc. 265,000 £10,533,750
Canaccord Genuity Group Inc 259,940 £10,332,615
Gresham House Asset Management Limited 259,116 £10,299,861
Adrian Williams 253,372 £10,071,537
Danske Bank A/S 206,515 £8,208,971

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,975.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 4,500.00
52 Week Low 3,825.00
Volume 2,009
Shares Issued 5.21m
Market Cap £207.07m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.13% below the market average84.13% below the market average84.13% below the market average84.13% below the market average84.13% below the market average
88% below the sector average88% below the sector average88% below the sector average88% below the sector average88% below the sector average
Price Trend
46.47% below the market average46.47% below the market average46.47% below the market average46.47% below the market average46.47% below the market average
25.81% below the sector average25.81% below the sector average25.81% below the sector average25.81% below the sector average25.81% below the sector average
Income Not Available
Growth
77.40% above the market average77.40% above the market average77.40% above the market average77.40% above the market average77.40% above the market average
Sector averageSector averageSector averageSector averageSector average

Bioventix Dividends

  Latest Previous
  1st Interim Special
Ex-Div 08-Apr-21 29-Oct-20
Paid 23-Apr-21 13-Nov-20
Amount 43.00p 53.00p

Trades for 24-Sep-2021

Time Volume / Share Price
16:35 413 @ 3,974.76p
16:34 414 @ 3,974.76p
15:21 5 @ 3,975.00p
15:02 56 @ 4,000.00p
14:30 25 @ 3,975.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page